Related Experiment Video
Updated: Jun 15, 2026
13:49
Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates
Published on: December 6, 2017
mRNA display selection of a high-affinity, Bcl-X(L)-specific binding peptide
Nobutaka Matsumura1, Toru Tsuji, Takeshi Sumida
1Department of Biosciences and Informatics, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan.
Summary
Researchers identified novel peptides that target Bcl-X(L), a protein involved in cell death. These peptides, selected using mRNA display, show high affinity and can induce cell death, offering potential for new drug discovery targeting anti-apoptotic proteins.
Area of Science:
- Molecular Biology
- Drug Discovery
- Biochemistry
Background:
- Bcl-X(L) is an anti-apoptotic protein that inhibits programmed cell death.
- Targeting Bcl-X(L) is a promising strategy for cancer therapy.
- Peptides offer high specificity and affinity for therapeutic applications.
Purpose of the Study:
- To identify novel peptide inhibitors of Bcl-X(L) using mRNA display.
- To characterize the binding affinity and specificity of selected peptides.
- To evaluate the therapeutic potential of these peptides in cell-based assays.
Main Methods:
- Selection of 16-mer peptides from random libraries via mRNA display.
- In vitro binding assays to determine affinity for Bcl-X(L).
- Cell-based assays using GFP-fused peptides and chimeric molecules to assess mitochondrial localization and cell death induction.
Main Results:
- Identified peptides with sequence similarity to BH3 domains, exhibiting high affinity for Bcl-X(L).
- One selected peptide demonstrated significantly higher affinity for Bcl-X(L) than native Bak BH3.
- Selected peptides localized to mitochondria and induced cell death, antagonizing Bcl-X(L) function.
Conclusions:
- mRNA display is effective for discovering high-affinity peptide inhibitors of disease-related proteins.
- The identified peptides specifically target and inhibit Bcl-X(L) activity.
- These peptides hold potential as therapeutic agents for diseases involving Bcl-X(L) overexpression.
